Today: 13 May 2026
IREN Stock Price Slips as $6 Billion Share-Sale Plan Tests AI Buildout
13 March 2026
2 mins read

IREN Stock Price Slips as $6 Billion Share-Sale Plan Tests AI Buildout

NEW YORK, March 12, 2026, 6:15 PM EDT

IREN slipped roughly 1.3% to $41.37 on Thursday, surrendering some of Wednesday’s sharp 10% rally. Pressure from a broader pullback in U.S. growth stocks weighed on the shares. The Nasdaq Composite lost 1.78%, with traders on edge over rallying oil prices and heightened Middle East tensions.

This is significant: IREN is deep into a pricey transition, moving out of bitcoin mining and into AI cloud services. Back on March 4, it announced plans to pick up more than 50,000 Nvidia B300 GPUs—the same chips powering today’s AI models. The company also boosted its at-the-market stock-sale program, giving it the option to issue fresh shares gradually.

IREN expects its expanded hardware to push the total GPU count to 150,000, a boost that, by the end of 2026, could drive more than $3.7 billion in AI-cloud annualized run-rate revenue—a ballpark figure for potential yearly sales at that scale. “Scaling to 150,000 GPUs positions IREN among the largest AI cloud infrastructure providers globally,” co-CEO Daniel Roberts said. Nasdaq

Financing remains the sticking point for many investors. According to a March 4 SEC filing, IREN now has authorization to sell as much as $6 billion in ordinary shares—this comes after tapping out a previous $1 billion facility, with 66.7 million shares already sold for roughly $1 billion. The prospectus flagged the risk: additional share sales could dilute existing holdings, cutting investors’ stakes and potentially weighing on the stock.

IREN described the equity program as an addition to its existing funding mix as the company ramps up. In its March 4 statement, the firm said it had lined up $9.3 billion in funding over the past eight months. Management is planning for another $3.5 billion in capital outlays for new GPU orders, set for the back half of 2026.

Even so, the most recent quarter lays bare the market’s skepticism. For the three months ending Dec. 31, total revenue dropped 23.1% sequentially to $184.7 million. IREN booked a net loss of $155.4 million. Bitcoin mining brought in $167.4 million in sales; AI cloud services contributed just $17.3 million.

Management insists demand isn’t the issue. Back in February, Roberts described IREN’s situation as “the strongest demand environment to date,” highlighting over 4.5 gigawatts of locked-in power for the next stage of expansion. Nasdaq

There’s at least one big-name client. Back in November, Reuters reported that Microsoft lined up a $9.7 billion, five-year deal with IREN for Nvidia-powered cloud resources—a contract that quickly shifted investor perception, pushing the company squarely into the AI infrastructure spotlight.

IREN wasn’t alone in Thursday’s slide. Shares in Applied Digital ended down around 3.7%, Cipher Digital lost close to 2.8%, and Core Scientific shed 1.8%. The moves point to broader selling pressure in riskier tech stocks as investors trimmed positions.

Still, hitting that upside depends on how well IREN delivers. The company puts its $3.7 billion AI revenue projection down to internal modeling, not solid contracts, while Cantor Fitzgerald’s Brett Knoblauch flagged investor worry about “capex, financing cost, and ultimately returns” in his February note. Right now, the shares are caught—caught between bets on massive growth and nagging questions about just how much cash and fresh equity will be needed to pull it off. Nasdaq

Stock Market Today

  • 10x Genomics Shares Drop 5.3% After Q1 Revenue Miss Raises Growth Fears
    May 13, 2026, 12:21 AM EDT. 10x Genomics (TXG) shares fell 5.3% following quarterly results that beat forecasts but showed a 2.6% revenue decline year-over-year to $150.8 million. Despite narrowing losses and reconfirming full-year guidance, investors reacted to concerns about future growth prospects. The stock closed at $21.61, down 3.6% from the previous close. Volatility remains high with 54 price swings over 5% in the past year. Investor caution appears linked to weaker growth signals in the life sciences sector, highlighted by peer Thermo Fisher's slower organic revenue gain. Although 10x Genomics is up 29.9% year-to-date, shares remain 17.2% below their 52-week peak. The market seems to weigh near-term sales softness against long-term potential cautiously.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.05.2026

13 May 2026
LIVEMarkets rolling coverageStarted: May 13, 2026, 12:00 AM EDTUpdated: May 13, 2026, 12:33 AM EDT 10x Genomics Shares Drop 5.3% After Q1 Revenue Miss Raises Growth Fears May 13, 2026, 12:21 AM EDT. 10x Genomics (TXG) shares fell 5.3% following quarterly results that beat forecasts but showed a 2.6% revenue decline year-over-year to $150.8 million. Despite narrowing losses and reconfirming full-year guidance, investors reacted to concerns about future growth prospects. The stock closed at $21.61, down 3.6% from the previous close. Volatility remains high with 54 price swings over 5% in the past year. Investor caution appears linked to weaker
US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

13 May 2026
Tech stocks led declines Tuesday after April CPI data showed consumer prices rose 0.6% for the month and 3.8% year-over-year, pushing Treasury yields higher and weighing on rate-cut hopes. Brent crude settled above $107, fueling inflation concerns. The S&P 500 slipped 11.88 points to 7,400.96, while the Nasdaq lost 185.92 to 26,088.20. Chip stocks fell sharply, with Qualcomm down 11% and Intel off 6.8%.
Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

13 May 2026
Karman Holdings shares closed up 6.2% at $62.48 on May 12, then fell 11% after hours following first-quarter results and a raised 2026 outlook. Q1 revenue jumped 51% to $151.2 million, net income reached $7.8 million, and backlog hit $1.0 billion. Adjusted EPS matched the $0.11 estimate. The company announced over $1 billion in new contingent demand commitments.
Silver Price Today: Spot Silver Rebounds After Selloff as Dollar Strength Caps Gains
Previous Story

Silver Price Today: Spot Silver Rebounds After Selloff as Dollar Strength Caps Gains

Nvidia Stock Price: NVDA Near $183 Ahead of GTC as Wall Street Seeks Fresh AI Catalyst
Next Story

Nvidia Stock Price: NVDA Near $183 Ahead of GTC as Wall Street Seeks Fresh AI Catalyst

Go toTop